Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

News Industry News TCT 2016

Imaging Study Shows Rate of Strut Coverage and Low Rates of Neouatherosclerosis with Thin Strut Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

November 02, 2016

News Industry News TCT 2016

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

November 02, 2016

News Industry News

Very Thin-Strut Biodegradable Polymer Everolimus-Eluting And Sirolimus-Eluting Stents Shown To Be Non-Inferior To Durable Polymer Zotarolimus-Eluting Stents In All-Comers With Coronary Artery Disease

October 30, 2016

News Industry News

Latest Data Shows OrbusNeich’s COMBO™ Dual Therapy Stent has Excellent Healing Benefits

September 18, 2014

News Industry News

New Study Evaluates the Safety and Efficacy of Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Patients with Coronary Artery Disease

September 16, 2014

News Industry News

Elixir Medical Announces Schedule of Programs for TCT 2014

September 08, 2014

News Industry News

First patient enrollment in MASCOT registry represents major milestone for COMBO™ Dual Therapy Stent and OrbusNeich’s clinical program

July 16, 2014

News Industry News

OrbusNeich Announces First Patient Enrollment in Physician-Initiated Study to Evaluate the Potential for Shorter-Term Dual Antiplatelet Therapy in ACS Patients

June 19, 2014

News Industry News

Elixir Medical Announces Outstanding Long-term Clinical Results at EuroPCR for World’s Broadest Portfolio of Three CE Mark-approved Novolimus Eluting Coronary Intervention Systems

May 23, 2014

News Industry News

Biosensors Launches Larger 4.0 x 9mm Axxess™ Size, utilized in Live Left Main case from Sau Paulo

October 31, 2013

News Industry News

New Study Compares Two Newer Generation Drug-Eluting Stents with Biocompatible and Biodegradable Polymers

October 29, 2013

News Industry News

OrbusNeich Launches World’s First Dual Therapy Stent That Addresses Challenges of Delayed Coronary Artery Healing Associated with Monotherapy Drug Eluting Stents

May 27, 2013

News Industry News

Cardiovascular Summit TCTAP 2013 Symposium to Feature OrbusNeich’s COMBO Dual Therapy Stent™

April 22, 2013

News Industry News

Cardionovum® expects to launch next-generation product: drug-eluting coronary stent system, PROLIMUS Biograde

August 08, 2012

News Industry News

Clinical trial of a new dual therapy stent establishes non-inferiority compared to paclitaxel-eluting stent

November 10, 2011

News Industry News

Elixir Medical Corporation Announces Excellent Six-Month Safety and Efficacy Results from the EXCELLA BD Randomized Clinical Trial

November 08, 2011

News Industry News

Axxess Self-Expanding Bifurcation Drug-Eluting Stent Shown To Be Safe And Effective Up To Five Years

November 07, 2011

News Industry News

Sahajanand Medical Technologies, India Receives CE Mark on Two Sirolimus Eluting Coronary Stents

June 26, 2011

News Industry News

New Data Confirms Safety of BioMatrix™ at One Year

May 19, 2011

News Industry News

Axxess™ Self-Expanding Bifurcation Drug-Eluting Stent Shown To Be Safe And Effective Up To Three Years

May 19, 2011

Advertisement

Imaging Study Shows Rate of Strut Coverage and Low Rates of Neouatherosclerosis with Thin Strut Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

Very Thin-Strut Biodegradable Polymer Everolimus-Eluting And Sirolimus-Eluting Stents Shown To Be Non-Inferior To Durable Polymer Zotarolimus-Eluting Stents In All-Comers With Coronary Artery Disease

Latest Data Shows OrbusNeich’s COMBO™ Dual Therapy Stent has Excellent Healing Benefits

New Study Evaluates the Safety and Efficacy of Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Patients with Coronary Artery Disease

Elixir Medical Announces Schedule of Programs for TCT 2014

First patient enrollment in MASCOT registry represents major milestone for COMBO™ Dual Therapy Stent and OrbusNeich’s clinical program

OrbusNeich Announces First Patient Enrollment in Physician-Initiated Study to Evaluate the Potential for Shorter-Term Dual Antiplatelet Therapy in ACS Patients

Elixir Medical Announces Outstanding Long-term Clinical Results at EuroPCR for World’s Broadest Portfolio of Three CE Mark-approved Novolimus Eluting Coronary Intervention Systems

Biosensors Launches Larger 4.0 x 9mm Axxess™ Size, utilized in Live Left Main case from Sau Paulo

New Study Compares Two Newer Generation Drug-Eluting Stents with Biocompatible and Biodegradable Polymers

OrbusNeich Launches World’s First Dual Therapy Stent That Addresses Challenges of Delayed Coronary Artery Healing Associated with Monotherapy Drug Eluting Stents

Cardiovascular Summit TCTAP 2013 Symposium to Feature OrbusNeich’s COMBO Dual Therapy Stent™

Cardionovum® expects to launch next-generation product: drug-eluting coronary stent system, PROLIMUS Biograde

Clinical trial of a new dual therapy stent establishes non-inferiority compared to paclitaxel-eluting stent

Elixir Medical Corporation Announces Excellent Six-Month Safety and Efficacy Results from the EXCELLA BD Randomized Clinical Trial

Axxess Self-Expanding Bifurcation Drug-Eluting Stent Shown To Be Safe And Effective Up To Five Years

Sahajanand Medical Technologies, India Receives CE Mark on Two Sirolimus Eluting Coronary Stents

New Data Confirms Safety of BioMatrix™ at One Year

Axxess™ Self-Expanding Bifurcation Drug-Eluting Stent Shown To Be Safe And Effective Up To Three Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content